R. Maarten Egeler
University of Toronto
142 Papers
947 Citations
R. Maarten Egeler is an academic researcher from University of Toronto. The author has contributed to research in topics: Langerhans cell histiocytosis & Medicine. The author has an hindex of 49, co-authored 135 publications. Previous affiliations of R. Maarten Egeler include Alberta Children's Hospital & Hospital for Sick Children.
Chat about Author
Papers
Pulmonary hypertension in two severe combined immunodeficiency disease patients posthaematopoietic stem cell transplantation
Robbert G. M. Bredius,Maria Ouachee,Ronald Van Brempt,Regina Bökenkamp,Arjan C. Lankester,Koert M. Dolman,R. Maarten Egeler,Alain Fischer +7 more
TL;DR: It is reported that not only osteopetrosis patients are susceptible to PH in the post-HSCT period, and two cases with severe immunodeficiency syndrome (SCID) that developed this complication are reported.
7
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in the First Prospective Multicenter Trial for Pediatric, Adolescent, and Young Adult Patients with High Risk Acute Leukemias and Myelodysplastic Syndrome
Heather J. Symons,Andrew Cluster,Emi Caywood,Jignesh Dalal,R. Maarten Egeler,Jeffrey S. Huo,Michelle Hudspeth,Amy K. Keating,Susan Kelly,Joerg Krueger,Dean A. Lee,Leslie Lehmann,Lisa Madden,Benjamin R. Oshrine,Heather Schneider,Kirk R. Schultz,Michael A. Pulsipher,Terry J. Fry +17 more
TL;DR: In this article, the first prospective multicenter pilot trial in the Pediatric Blood and Marrow Transplant Consortium (PBMTC) for high risk acute leukemias and myelodysplastic syndrome (MDS) was reported.
6
Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.
Christian M. Capitini,Laurence J.N. Cooper,R. Maarten Egeler,Rupert Handgretinger,Franco Locatelli,Paul M. Sondel,Crystal L. Mackall +6 more
TL;DR: The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatricOncology.